FLT1 and neoplasm: Unlike previous studies, we did not infuse exogenous BMDCs into the mouse model of tumor metastasis, but we did observe increasing recruitment of endogenous VEGFR1+CD133+ HPCs to the lung during the progression of lung metastasis and a peak in this recruitment on day 70 after injection.